TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes
Tóm tắt
The specific signals mediating the activation of microglia and astrocytes as a prelude to, or consequence of, CNS inflammation continue to be defined. We investigated TLRs as novel receptors mediating innate immune responses in human glial cells. We find that microglia express mRNA for TLRs 1–9, whereas astrocytes express robust TLR3, low-level TLR 1, 4, 5, and 9, and rare-to-undetectable TLR 2, 6, 7, 8, and 10 mRNA (quantitative real-time PCR). We focused on TLRs 3 and 4, which can signal through both the MyD88-dependent and -independent pathways, and on the MyD88-restricted TLR2. By flow cytometry, we established that microglia strongly express cell surface TLR2; TLR3 is expressed at higher levels intracellularly. Astrocytes express both cell surface and intracellular TLR3. All three TLRs trigger microglial activation upon ligation. TLR3 signaling induces the strongest proinflammatory polarizing response, characterized by secretion of high levels of IL-12, TNF-α, IL-6, CXCL-10, and IL-10, and the expression of IFN-β. CXCL-10 and IL-10 secretion following TLR4 ligation are comparable to that of TLR3; however, other responses were lower or absent. TLR2-mediated responses are dominated by IL-6 and IL-10 secretion. Astrocytes respond to TLR3 ligation, producing IL-6, CXCL-10, and IFN-β, implicating these cells as contributors to proinflammatory responses. Initial TLR-mediated glial activation also regulates consequent TLR expression; while TLR2 and TLR3 are subject to positive feedback, TLR4 is down-regulated in microglia. Astrocytes up-regulate all three TLRs following TLR3 ligation. Our data indicate that activation of innate immune responses in the CNS is not homogeneous but rather tailored according to cell type and environmental signal.
Từ khóa
Tài liệu tham khảo
Reis e Sousa, C.. 2004. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 16:27.-34.
Becher, B., A. Prat, J. P. Antel. 2000. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29:293.-304.
Zeinstra, E., N. Wilczak, C. Streefland, J. De Keyser. 2000. Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 11:89.-91.
Zeinstra, E., N. Wilczak, J. De Keyser. 2003. Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J. Neuroimmunol. 135:166.-171.
Gehrmann, J., R. B. Banati, M. L. Cuzner, G. W. Kreutzberg, J. Newcombe. 1995. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15:141.-151.
Medzhitov, R., C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298.-300.
Panitch, H. S.. 1994. Influence of infection on exacerbations of multiple sclerosis. Ann. Neurol. 36:(Suppl.):S25.-S28.
Alvarez-Lafuente, R., V. De las Heras, M. Bartolome, J. J. Picazo, R. Arroyo. 2004. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch. Neurol. 61:1523.-1527.
Barnett, M. H., J. W. Prineas. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55:458.-468.
Contini, C., R. Cultrera, S. Seraceni, M. Castellazzi, E. Granieri, E. Fainardi. 2004. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult. Scler. 10:360.-369.
Beutler, B.. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257.-263.
Iwasaki, A., R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987.-995.
Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198:1043.-1055.
Revets, H., G. Pynaert, J. Grooten, P. De Baetselier. 2005. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J. Immunol. 174:1097.-1103.
Rehli, M.. 2002. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23:375.-378.
Heinz, S., V. Haehnel, M. Karaghiosoff, L. Schwarzfischer, M. Muller, S. W. Krause, M. Rehli. 2003. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol. Chem. 278:21502.-21509.
Carpentier, P. A., W. S. Begolka, J. K. Olson, A. Elhofy, W. J. Karpus, S. D. Miller. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360.-374.
Visintin, A., A. Mazzoni, J. H. Spitzer, D. H. Wyllie, S. K. Dower, D. M. Segal. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166:249.-255.
Olson, J. K., S. D. Miller. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916.-3924.
Bsibsi, M., R. Ravid, D. Gveric, J. M. van Noort. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013.-1021.
Yong, V. W., J. P. Antel. 1992. Culture of glial cells from human brain biopsies. S. Sedorf, Jr, and A. Richardson, Jr, eds. Protocols for Neural Cell Culture 81.-96. Plenum Publishing, New York.
Pouly, S., B. Becher, M. Blain, J. P. Antel. 1999. Expression of a homologue of rat NG2 on human microglia. Glia 27:259.-268.
D’Souza, S., K. Alinauskas, E. McCrea, C. Goodyer, J. P. Antel. 1995. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15:7293.-7300.
Wosik, K., B. Becher, A. Ezman, J. Nalbantoglu, J. P. Antel. 2001. Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes. Glia 33:217.-224.
Seguin, R., Z. Moditi, R. Rotondo, K. Biernacki, K. Wosik, A. Prat, J. P. Antel. 2003. Human brain endothelial cells supply support for monocyte immunoregulatory functions. J. Neuroimmunol. 135:96.-106.
Farina, C., M. Krumbholz, T. Giese, G. Hartmann, F. Aloisi, E. Meinl. 2005. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159:12.-19.
Kielian, T., P. Mayes, M. Kielian. 2002. Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J. Neuroimmunol. 130:86.-99.
Schrijver, I. A., M. van Meurs, M. J. Melief, A. C. Wim, D. Buljevac, R. Ravid, M. P. Hazenberg, J. D. Laman. 2001. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 124:1544.-1554.
Matsumoto, M., K. Funami, M. Tanabe, H. Oshiumi, M. Shingai, Y. Seto, A. Yamamoto, T. Seya. 2003. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171:3154.-3162.
Kariko, K., H. Ni, J. Capodici, M. Lamphier, D. Weissman. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279:12542.-12550.
Redecke, V., H. Hacker, S. K. Datta, A. Fermin, P. M. Pitha, D. H. Broide, E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:2739.-2743.
Jotwani, R., B. Pulendran, S. Agrawal, C. W. Cutler. 2003. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur. J. Immunol. 33:2980.-2986.
Eder, W., W. Klimecki, L. Yu, E. von Mutius, J. Riedler, C. Braun-Fahrlander, D. Nowak, F. D. Martinez. 2004. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. Allergy Clin. Immunol. 113:482.-488.
Dillon, S., A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, B. Pulendran. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172:4733.-4743.
Pisegna, S., G. Pirozzi, M. Piccoli, L. Frati, A. Santoni, G. Palmieri. 2004. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104:4157.-4164.
Nagai, T., O. Devergne, T. F. Mueller, D. L. Perkins, J. M. van Seventer, G. A. van Seventer. 2003. Timing of IFN-β exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-β-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J. Immunol. 171:5233.-5243.
Becher, B., V. Dodelet, V. Fedorowicz, J. P. Antel. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1539.-1543.
Kapsenberg, M. L.. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3:984.-993.
Boonstra, A., C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y. J. Liu, A. O’Garra. 2003. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation. J. Exp. Med. 197:101.-109.
Adib-Conquy, M., J. M. Cavaillon. 2002. γ Interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J. Biol. Chem. 277:27927.-27934.
Visser, L., H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M. J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, J. D. Laman. 2005. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J. Immunol. 174:808.-816.
Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551.-560.